José Alberto Nakauma-González

6PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Proceedings of the first international NMIBC consensus classification meeting.

|Mar 14, 2025
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

Khrystany T Isebia, Anouk C de Jong, Lisanne F van Dessel

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Feb 14, 2024
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.

Maud Rijnders, J Alberto Nakauma-González, Debbie G J Robbrecht

|Feb 19, 2022
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.

Pauline A J Mendelaar, Debbie G J Robbrecht, Maud Rijnders

|Oct 07, 2021
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells.

Maud Rijnders, Hayri E Balcioglu, Debbie G J Robbrecht

Pageof 1

Frequent Collaborators

3 joint publications

Debbie G J Robbrecht

2 joint publications

Hayri E Balcioglu

2 joint publications

Geert J L H van Leenders

2 joint publications

Jens Voortman